Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?

被引：28
|
作者：
Abobaker, Anis [1 ]
机构：
[1] Spire Fylde Coast Hosp, St Walburgas Rd, Blackpool FY3 8BP, England
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2020年 / 76卷 / 11期
关键词：
INFECTION; DEFEROXAMINE; CELLS;
D O I：
10.1007/s00228-020-02942-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1619 / 1620
页数：2
相关论文
共 50 条
  • [1] Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
    Dalamaga, Maria
    Karampela, Irene
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 108
  • [2] Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?
    Vlahakos, Vassilios D.
    Marathias, Katerina P.
    Arkadopoulos, Nikolaos
    Vlahakos, Demetrios V.
    ARTIFICIAL ORGANS, 2021, 45 (02) : 163 - 167
  • [3] Clinical course and outcome in diabetic patients with COVID-19
    Davoudi, Zahra
    Darazam, Ilad Alavi
    Saberian, Farnaz
    Homaee, Sina
    Shokouhi, Shervin
    Shabani, Minoosh
    Gachkar, Latif
    IMMUNOPATHOLOGIA PERSA, 2021, 7 (02):
  • [4] Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19
    Kim, Sang Hyuk
    Kim, Taehee
    Choi, Hayoung
    Shin, Tae Rim
    Sim, Yun Su
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [5] Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
    Rossi, Giovanni A.
    Sacco, Oliviero
    Capizzi, Antonino
    Mastromarino, Paola
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] The role of berberine in Covid-19: potential adjunct therapy
    Babalghith, Ahmad O.
    Al-Kuraishy, Hayder M.
    Al-Gareeb, Ali, I
    De Waard, Michel
    Al-Hamash, Sadiq Mohammed
    Jean-Marc, Sabatier
    Negm, Walaa A.
    Batiha, Gaber El-Saber
    INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 2003 - 2016
  • [7] Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
    Karampela, Irene
    Dalamaga, Maria
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (07) : 741 - 742
  • [8] Is Ozone therapy an adjunct treatment for SARS-CoV-2 / COVID-19 infection?
    Ivan Arias-Vazquez, Pedro
    Arcila-Novelo, Russell
    Antonieta Ramirez-Wakamatzu, Maria
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [9] Neurological features and outcome in COVID-19: dementia can predict severe disease
    Ghaffari, Mehran
    Ansari, Hossein
    Beladimoghadam, Nahid
    Aghamiri, Seyed Hossein
    Haghighi, Mehrdad
    Nabavi, Mahmoud
    Mansouri, Behnam
    Mehrpour, Masoud
    Assarzadegan, Farhad
    Hesami, Omid
    Sedaghat, Meghdad
    Farahbakhsh, Mohammad
    Lima, Behnam Safarpour
    JOURNAL OF NEUROVIROLOGY, 2021, 27 (01) : 86 - 93
  • [10] Are Multiple Chemosensory Systems Accountable for COVID-19 Outcome?
    Caretta, Antonio
    Mucignat-Caretta, Carla
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
12345